JBIO - Jade Biosciences, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
5/19/25 16:54	5/16/25	JBIO	Health	Drug	Pharmaceutical Preparations	Frohlich Tom	MA	DO	Chief Ex	P	44	7.40	6	New	6	D
6/20/24 17:56	6/17/24	AVTE	Health	Drug	Pharmaceutical Preparations	Ra Capital Management, L.P.	MA	DT		P	1,550	1.67	928	11	9,192	I
7/7/21 16:45	7/2/21	AVTE	Health	Drug	Pharmaceutical Preparations	Cormorant Asset Management, LP	MA	H	Former 1	P.d	7,000	14.00	500	33	2,031	I
7/6/21 17:03	7/2/21	AVTE	Health	Drug	Pharmaceutical Preparations	Ra Capital Management, L.P.	MA	DT		P.d	39,000	14.00	2,786		311	I
7/6/21 16:28	7/2/21	AVTE	Health	Drug	Pharmaceutical Preparations	Sofinnova Venture Partners X, L.P.	CA	T		P.d	5,000	14.00	357	10	3,759	D
7/6/21 16:27	7/2/21	AVTE	Health	Drug	Pharmaceutical Preparations	Katabi Maha	MA	DT		P.d	5,000	14.00	357	10	3,759	I
7/6/21 16:27	7/2/21	AVTE	Health	Drug	Pharmaceutical Preparations	Grayzel David S.	MA	D		P.d	7,500	14.00	536	21	3,104	I
7/6/21 16:26	7/2/21	AVTE	Health	Drug	Pharmaceutical Preparations	Atlas Venture Fund Xii, L.P.	MA	T		P.d	7,500	14.00	536	21	3,104	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person